Check-Cap Ltd MBAI
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.66
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D | — | — | $8.3M | $14.3M | $12.3M | $10.0M | $10.5M | $7.6M | $6.8M | $5.5M |
| SG&A | $2.4M | $9.5M | $9.6M | $5.8M | $5.0M | $3.9M | $3.6M | $3.4M | $3.2M | $3.6M |
| Operating income | -$2.4M | -$9.5M | -$19.3M | -$20.0M | -$17.3M | -$13.9M | -$14.1M | -$11.1M | -$10.0M | -$9.1M |
| Interest expense | — | — | $13.0K | $12.0K | $13.0K | $12.0K | $8.0K | $7.0K | $7.0K | $7.0K |
| Pre-tax income | — | — | — | — | — | -$13.8M | -$13.8M | -$10.6M | -$9.8M | -$8.8M |
| Income tax | — | — | — | — | — | — | — | $1.0K | $6.0K | $8.0K |
| Net income | $4.1M | -$25.1M | -$17.6M | -$19.1M | -$17.2M | -$13.8M | -$13.8M | -$10.6M | -$9.8M | -$8.8M |
| EPS, basic | 0.66 | -4.30 | -3.00 | 3.37 | 4.14 | 9.01 | — | — | — | — |
| EPS, diluted | 0.66 | -4.30 | -3.00 | 3.37 | 4.14 | 9.01 | 1.73 | 2.61 | 6.72 | 7.31 |
| Shares, diluted (wtd. avg.) | 6.2M | 5.8M | 5.8M | 5.7M | 4.2M | 1.5M | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.0K | — | $8.8M | $4.4M | $26.8M | $8.1M | $8.0M | $8.9M | $7.0M | $11.6M |
| Short-term investments | $217.0K | $265.0K | $15.9M | $37.6M | $25.1M | $10.1M | — | $5.6M | — | — |
| Total current assets | $219.0K | $265.0K | $24.9M | $42.6M | $52.8M | $18.4M | $8.4M | $15.0M | $7.4M | $11.9M |
| Property, plant and equipment | — | — | $161.0K | $1.8M | $1.8M | $823.0K | $540.0K | $452.0K | $503.0K | $414.0K |
| Other intangibles | $726.0K | — | — | — | — | — | — | — | — | — |
| Total assets | $7.5M | $377.0K | $25.0M | $45.4M | $55.7M | $19.6M | $9.4M | $15.4M | $7.9M | $12.3M |
| Accounts payable | — | — | — | $952.0K | $1.1M | $862.0K | $989.0K | $1.1M | $608.0K | $393.0K |
| Total current liabilities | $4.0M | $1.8M | $1.3M | $3.4M | $4.0M | $3.0M | $2.8M | $2.2M | $1.6M | $1.4M |
| Total liabilities | — | $1.8M | $1.3M | — | — | — | — | — | — | — |
| Retained earnings | -$165.9M | -$170.0M | -$144.9M | -$127.3M | -$108.2M | -$91.0M | -$77.1M | -$63.3M | -$52.7M | -$42.9M |
| Total equity | $3.4M | -$1.4M | $23.7M | $41.3M | $50.7M | $16.4M | $6.2M | $13.0M | $5.9M | $10.4M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$46.0K | -$8.0M | -$17.0M | -$18.7M | -$16.3M | -$13.1M | -$12.8M | -$10.1M | -$9.0M | -$7.9M |
| Depreciation and amortisation | — | $161.0K | $212.0K | $404.0K | $205.0K | $148.0K | $115.0K | $147.0K | $157.0K | $130.0K |
| Stock-based compensation | -$12.0K | $12.0K | -$57.0K | $879.0K | $491.0K | $408.0K | $516.0K | -$65.0K | $726.0K | $1.2M |
| Capital expenditure | — | — | $83.0K | $486.0K | $1.0M | $379.0K | $167.0K | $94.0K | $231.0K | $166.0K |
| Investing cash flow | $48.0K | -$840.0K | $21.4M | -$12.5M | -$16.0M | -$10.5M | $5.4M | -$5.7M | -$231.0K | $4.6M |
| Financing cash flow | — | — | — | $8.8M | $51.0M | $23.6M | $6.5M | $17.8M | $4.6M | $5.4M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-048090.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | -$8.8M | -$9.8M | -$10.6M | -$13.8M | -$13.8M | -$17.2M | -$19.1M | -$17.6M | -$25.1M | $4.1M |
Others in SIC 3844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | $32.50B | 15.7x | 4.8% |
| BFLY | Butterfly Network, Inc. | $1.77B | — | 19.0% |
| PHG | KONINKLIJKE PHILIPS NV | — | — | — |
| NNOX | Nano-X Imaging Ltd. | — | — | 15.4% |